Monoaminergic compensation in the neuropeptide Y deficient mouse brain

Neuropeptides

Volumn 42, Issue 3, 2008, Pages 367-375

  Gehlert, Donald R ^a   Thompson, Linda K ^a   Hemrick Luecke, Susan K ^a   Shaw, Janice ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Anxiety; Autoradiography; Brain; Depression; Hypothalamus; Knockout mice; Norepinephrine transporter; Obesity; Serotonin transporter; Tyrosine hydroxylase

Indexed keywords

BRAIN MONOAMINE; CITALOPRAM; NEUROPEPTIDE Y; NISOXETINE; NORADRENALIN; NORADRENALIN TRANSPORTER; TRITIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; GLOMERULUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; OLFACTORY BULB; OLFACTORY NUCLEUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RADIOIMMUNOLOGY; THALAMUS; WILD TYPE;

ANIMALS; AUTORADIOGRAPHY; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; FLUOXETINE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; NEUROPEPTIDE Y; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 44649085717     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2007.10.005     Document Type: Article

References (44)

1. Adewale A.S., Macarthur H., and Westfall T.C. Neuropeptide Y induced modulation of dopamine synthesis in the striatum. Regulatory Peptides 129 (2005) 73-78
2. Allen A.J., Kurlan R.M., Gilbert D.L., Coffey B.J., Linder S.L., Lewis D.W., Winner P.K., Dunn D.W., Dure L.S., Sallee F.R., Milton D.R., Mintz M.I., Ricardi R.K., Erenberg G., Layton L.L., Feldman P.D., Kelsey D.K., and Spencer T.J. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 65 (2005) 1941-1949
3. Berglund M.M., Hipskind P.A., and Gehlert D.R. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Experimental Biology & Medicine 228 (2003) 217-244
4. Cavadas C., Cefai D., Rosmaninho-Salgado J., Vieira-Coelho M.A., Moura E., Busso N., Pedrazzini T., Grand D., Rotman S., Waeber B., Aubert J.F., and Grouzmann E. Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proceedings of the National Academy of Sciences of the USA 103 (2006) 10497-10502
5. Cortes V., Donoso M.V., Brown N., Fanjul R., Lopez C., Fournier A., and Huidobro-Toro J.P. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226. Journal of Pharmacology & Experimental Therapeutics 289 (1999) 1313-1322
6. Curzon G., Gibson E.L., and Oluyomi A.O. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends in Pharmacological Sciences 18 (1997) 21-25
7. Dryden S., Frankish H.M., Wang Q., Pickavance L., and Williams G. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 72 (1996) 557-566
8. Dube M.G., Sahu A., Phelps C.P., Kalra P.S., and Kalra S.P. Effect of d-fenfluramine on neuropeptide Y concentration and release in the paraventricular nucleus of food-deprived rats. Brain Research Bulletin 29 (1992) 865-869
9. El Bahh B., Cao J.Q., Beck-Sickinger A.G., and Colmers W.F. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. British Journal of Pharmacology 136 (2002) 502-509
10. El Bahh B., Balosso S., Hamilton T., Herzog H., Beck-Sickinger A.G., Sperk G., Gehlert D.R., Vezzani A., and Colmers W.F. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. European Journal of Neuroscience 22 (2005) 1417-1430
11. Gehlert D.R., and Heiman M. Obesity: leptin-neuropeptide Y interactions in the control of body weight. Annual Reports in Medicinal Chemistry 32 (1997) 21-30
12. Gehlert D.R., and Shaw J.L. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function. Peptides 28 (2007) 241-249
13. Gehlert D.R., Hemrick-Luecke S.K., Schober D.A., Krushinski J., Howbert J.J., Robertson D.W., Wong D.T., and Fuller R.W. (R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake. Life Sciences 56 (1995) 1915-1920
14. Gehlert D.R., Dreshfield L., Tinsley F., Benvenga M.J., Gleason S., Fuller R.W., Wong D.T., and Hemrick-Luecke S.K. The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding. Journal of Pharmacology & Experimental Therapeutics 287 (1998) 122-127
15. Guy J., Pelletier G., and Bosler O. Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleus. Neuroscience Letters 85 (1988) 9-13
16. Hollopeter G., Erickson J.C., Seeley R.J., Marsh D.J., and Palmiter R.D. Response of neuropeptide Y-deficient mice to feeding effectors. Regulatory Peptides 75-76 (1998) 383-389
17. Holmes A., Murphy D.L., and Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry 54 (2003) 953-959
18. Kakigi T., and Maeda K. Effect of serotonergic agents on regional concentrations of somatostatin- and neuropeptide Y-like immunoreactivities in rat brain. Brain Research 599 (1992) 45-50
19. Kalra S.P., and Crowley W.R. Norepinephrine-like effects of neuropeptide Y on LH release in the rat. Life Sciences 35 (1984) 1173-1176
20. le Roux C.W., and Bloom S.R. Peptide YY, appetite and food intake. Proceedings of the Nutrition Society 64 (2005) 213-216
21. Leibowitz S.F. Brain monoamines and peptides: role in the control of eating behavior. Federation Proceedings 45 (1986) 1396-1403
22. Leibowitz S.F., Sladek C., Spencer L., and Tempel D. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Research Bulletin 21 (1988) 905-912
23. Li A.J., and Ritter S. Glucoprivation increases expression of neuropeptide Y mRNA in hindbrain neurons that innervate the hypothalamus. European Journal of Neuroscience 19 (2004) 2147-2154
24. Lundberg J.M., Saria A., Franco-Cereceda A., Hokfelt T., Terenius L., and Goldstein M. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons. Naunyn Schmiedebergs Archives of Pharmacology 328 (1985) 331-340
25. 2+ channels and protein kinases. Journal of Neurochemistry 67 (1996) 1090-1099
26. Moltzen E.K., and Bang-Andersen B. Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century - a medicinal chemistry survey. Current Topics in Medicinal Chemistry 6 (2006) 1801-1823
27. Nelson D.L., and Gehlert D.R. Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29 (2006) 49-60
28. Niu C.S., Chang T.K., and Cheng J.T. Changes of neuropeptide Y messenger RNA and peptide by drugs influencing endogenous norepinephrine content in cerebrocortex of the rat. Journal of Neurochemistry 66 (1996) 2100-2104
29. Palmiter R.D., Erickson J.C., Hollopeter G., Baraban S.C., and Schwartz M.W. Life without neuropeptide Y. Recent Progress in Hormone Research 53 (1998) 163-199
30. Pelletier G. Ultrastructural localization of neuropeptide Y in the hypothalamus. Annals of the New York Academy of Sciences 611 (1990) 232-246
31. Redrobe J.P., Dumont Y., Fournier A., Baker G.B., and Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides 26 (2005) 1394-1400
32. Ritter S., Dinh T.T., and Li A.J. Hindbrain catecholamine neurons control multiple glucoregulatory responses. Physiology & Behavior 89 (2006) 490-500
33. Rogers P., McKibbin P.E., and Williams G. Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine. Peptides 12 (1991) 251-255
34. Rohner-Jeanrenaud F., Cusin I., Sainsbury A., Zakrzewska K.E., and Jeanrenaud B. The loop system between neuropeptide Y and leptin in normal and obese rodents. Hormone and Metabolic Research 28 (1996) 642-648
35. Schalling M., Franco-Cereceda A., Hokfelt T., Persson H., and Lundberg J.M. Increased neuropeptide Y messenger RNA and peptide in sympathetic ganglia after reserpine pretreatment. European Journal of Pharmacology 156 (1988) 419-420
36. Stanley B.G., Kyrkouli S.E., Lampert S., and Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7 (1986) 1189-1192
37. Stanley B.G., Anderson K.C., Grayson M.H., and Leibowitz S.F. Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiology & Behavior 46 (1989) 173-177
38. Taylor K., Lester E., Hudson B., and Ritter S. Hypothalamic and hindbrain NPY, AGRP and NE increase consummatory feeding responses. Physiology & Behavior 90 (2007) 744-750
39. Trivedi P.G., Yu H., Trumbauer M., Chen H., Van der Ploeg L.H., and Guan X. Differential regulation of neuropeptide Y receptors in the brains of NPY knock-out mice. Peptides 22 (2001) 395-403
40. Waldbillig R.J., Bartness T.J., and Stanley B.G. Increased food intake, body weight, and adiposity in rats after regional neurochemical depletion of serotonin. Journal of Comparative and Physiological Psychology 95 (1981) 391-405
41. Westfall T.C., Han S.P., Knuepfer M., Martin J., Chen X.L., del Valle K., Ciarleglio A., and Naes L. Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide. British Journal of Clinical Pharmacology 30 Suppl. 1 (1990) 75S-82S
42. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., and Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neuroscience 3 (2000) 465-471
43. Yokosuka M., Xu B., Pu S., Kalra P.S., and Kalra S.P. Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiology & Behavior 64 (1998) 331-338
44. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., and Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133 (1993) 1753-1758